miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes

Abstract

Hyperglycemic damage to the endothelial cells (ECs) leads to increased synthesis of inflammatory cytokines. We have previously shown miR-146a downregulation in ECs and in the tissues of diabetic mice. Here we investigated the role of miR-146a, in the production of specific inflammatory cytokines and extracellular matrix (ECM) proteins in retina and kidneys in diabetes. We generated an endothelial specific miR-146a overexpressing transgenic mice (TG). We investigated these mice and wild type (WT) controls with or without streptozotocin (STZ) induced diabetes. Retinal and renal cortical tissues from the mice were examined for mRNAs for specific inflammatory markers, (ECM) proteins and inflammation inducible transcription factor by real time RT-PCR. Corresponding proteins, where possible, were examined using immunofluorescence or ELISA. In parallel, we examined ECs following incubation with various levels of glucose with or without miR-146a mimic transfection. In the retina and kidneys of WT mice with diabetes, increased expression of inflammatory markers (IL-6, TNFα, IL1β) in association augmented expression of ECM proteins (collagen 1αIV, fibronectin) and NF κB-P65 were observed, compared to WT non-diabetic controls. These changes were prevented in diabetic miR-146a TG mice along with retinal and renal functional and structural changes. In vitro studies showed similar changes in the ECs exposed to high glucose. Such changes were corrected in the cells following miR-146a mimic transfection. Further analyses of renal cortical tissues showed diabetes induced significant upregulation of two regulators of NFκB, namely Interleukin-1 associated Kinase 1 and tumour necrosis factor receptor associated factor. Such changes were prevented in diabetic TG animals. These data indicate that augmented production of inflammatory cytokines and ECM proteins in the retina and kidneys in diabetes are regulated through endothelium derived miR-146a. Identification of such novel mechanisms may potentially lead to the development of novel therapies.

ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications

“…Measurement of urinary albumin and creatinine was performed by ELISA (Albuwell M; Exocell, Philadelphia, PA). All procedures were performed using the manufacturer's protocol, and the data were used to calculate urinary albumin/creatinine ratio (16).…”

MicroRNA‑146a/Toll‑like receptor 4 signaling protects against severe burn‑induced remote acute lung injury in rats via anti‑inflammation

“…MiR-146a downregulation may worsen inflammation within the ALI model. Chen et al (15) indicated that miR-146a may regulate glucose-induced inflammation of the retina and kidney in diabetes or animal/in vitro models. Endogenous nitric oxide (NO) is a free radical with high activity, and serves as a signaling molecule and a toxic molecule with diverse biological functions (4).…”

MALAT1: A regulator of inflammatory cytokines in diabetic complications

“…Plates were measured at 450 and 570 nm (to correct for plate defects) using a plate reader. For detection of albumin and creatinine in mouse urine, Albuwell™ and Creatinine Companion kits were used from Exocell (Philadelphia, PA, USA) …”